China: Draft Revision of GMP Annex for Sterile Drugs
The Chinese drug authority NMPA has published its long-awaited draft annex to the Chinese GMP for sterile drugs for public review and comment. There is close alignment with the tripartite WHO/EU/PICs GMP Annex that was published in 2022.
Unfortunately, there is no "official" English translation yet.
The NMPA invites comments until 30 May 2025.
Source:
NMPA: Draft Revision of GMP Annex for Sterile Drugs (2025) (3/17/2025)
Meet the GMP Compliance Adviser
The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business.
The demo access is non-binding and ends automatically.
You may also be interested in the following articles:
